Not Found
Digital Seminar

Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments


Faculty:
Russell A. Barkley, PhD
Duration:
3 Hours
Copyright:
Aug 28, 2018
Product Code:
POS052584
Media Type:
Digital Seminar
Access:
Never expires.


Description

The past 10-15 years have witnessed a number of major developments in the medications and delivery systems available for the management of ADHD.  Dr. Russell Barkley discusses the types of medications now available for ADHD management and the various delivery systems developed to extend the effectiveness of the medications across the day.  For each medication, he will present the major beneficial effects and side effects.  He will also discuss various issues clinicians should consider in selecting medications to use with a patient with ADHD, such as those issues related to the social context, the patient’s characteristics, and any comorbid conditions that may exist. 

This recording then moves on to an overview of the science-based approaches to the psychosocial management of ADHD.  It also discusses those treatments that, while popular, have little evidence for their effectiveness in managing the disorder. 

Handouts

Faculty

Russell A. Barkley, PhD's Profile

Russell A. Barkley, PhD Related seminars and products


Russell A. Barkley, PhD, is a Clinical Professor of Psychiatry at the Virginia Treatment Center for Children and Virginia Commonwealth University Medical Center, Richmond, VA.  He is a Diplomate (board certified) in three specialties, Clinical Psychology (ABPP), Clinical Child and Adolescent Psychology, and Clinical Neuropsychology (ABCN, ABPP).  Dr. Barkley is a clinical scientist, educator, and practitioner who has published 23 books, rating scales, and clinical manuals numbering 41 editions.  He has also published more than 270 scientific articles and book chapters related to the nature, assessment, and treatment of ADHD and related disorders and is the author of the book Managing ADHD in School (PESI, 2016).

He is the founder and editor of the bimonthly clinical newsletter, The ADHD Report, now in its 25th year of publication. Dr. Barkley has presented more than 800 invited addresses internationally and appeared on nationally televised programs such as 60 Minutes, The Today Show, Good Morning America, CBS Sunday Morning, CNN, and many other programs on behalf of those with ADHD.  He has received awards from the professional societies and ADHD organizations for his lifetime achievements, career accomplishments, contributions to research in ADHD, to clinical practice, and for the dissemination of science. His websites are russellbarkley.org and ADHDLectures.com.

Speaker Disclosures:

Financial: Dr. Russell Barkley is a published author and receives royalties. He receives a speaking honorarium, recording royalties, and book royalties from PESI, Inc. Dr. Barkley receive a speaking fee from Takeda Pharmaceutical Company, Astra-Zeneca Pharmaceutical Company, ContinuingEdCourses.net, and the American Psychological Association. All financial relationships with ineligible organizations have been mitigated.

Non-financial: Dr. Russell Barkley is voluntary faculty at the Virginia Commonwealth University School of Medicine. He is a member of the South Carolina Psychological Association and the American Professional Society for ADHD and Related Disorders (APSARD).


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Assess and characterize the utility of current FDA approved ADHD management medications for symptom management
  2. Discriminate between effective and unproven adjunctive ADHD interventions and its treatment implications
  3. Articulate the beneficial effects and potential side effects associated with ADHD medications in relation to assessment and treatment planning

Outline

Purpose of medication interventions

  • Stimulant medications most effective and well researched ADHD interventions
  • Safety, convenience and cost effectiveness are well established
Mechanisms of action for the three categories of ADHD medications Neurobiological mechanism of operation
  • Traditional stimulants as compared to new alpha-2a receptor conceptualizations
Primary US approved stimulant medications
  • Efficacy and factors in noncompliance
  • New developments in delivery systems 
  • OROS, Pulse delivery, transdermal, lisdexamfetamine
Stimulant efficacy in preschoolers
  • Gains smaller, side effects greater than in older children
Behavioral benefits of stimulant interventions
  • Academic, temperamental
Primary side effects of stimulant interventions
  • Insomnia, appetite suppression, head ache, gastric distress, cardiac effects
Common misconceptions related to stimulant use Predictors of positive response to medications Newer medication interventions
  • Atomoxetine – positive and side effects, rationale for use
  • Guanfacine XR - positive and side effects, rationale for use
Importance of early intervention in ADHD
  • Neuroprotective effects
Off label medications used for ADHD Factors involved in choosing which medication to use
  • Intervention context, patient characteristics, comorbidity
Conclusions
  • Evidence based treatments
  • Experimental psychosocial treatments
  • Nutritional interventions
  • Disproven therapies

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Marriage And Family Therapists
  • Speech-Language Pathologists
  • Teachers
  • School Administrators
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Nurses
  • Other Helping Professionals Who Work with Children

Please wait ...

Back to Top